Sana Biotechnology
Clinical trials sponsored by Sana Biotechnology, explained in plain language.
-
Engineered immune cells take on lupus and vasculitis in early trial
Disease control OngoingThis early-stage study tests a new treatment called SC291 for people with severe lupus or vasculitis that hasn't responded to other therapies. SC291 uses specially designed immune cells from a donor to target and destroy faulty immune cells causing the disease. The main goal is t…
Phase: PHASE1 • Sponsor: Sana Biotechnology • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Experimental 'Off-the-Shelf' cell therapy takes on tough blood cancers
Disease control OngoingThis early-stage study tests a new treatment called SC291 for people with certain types of blood cancer (non-Hodgkin lymphoma or chronic lymphocytic leukemia) that have come back or stopped responding to other treatments. SC291 is a type of CAR T cell therapy made from donor cell…
Phase: PHASE1 • Sponsor: Sana Biotechnology • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC